Gendell Jeffrey L Seelos Therapeutics, Inc. Transaction History

Gendell Jeffrey L

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.16 - $1.64 $252,250 - $2.59 Million	1,576,565 Added 30.51%	6,744,585 $1.21 Million
Q2 2023 Aug 11, 2023	BUY	$0.66 - $1.22 $66,000 - $122,000	100,000 Added 1.97%	5,168,020 $6.2 Million
Q1 2023 May 12, 2023	BUY	$0.59 - $1.04 $93,984 - $165,666	159,295 Added 3.25%	5,068,020 $3.5 Million
Q2 2022 Aug 12, 2022	SELL	$0.51 - $0.93 $12,392 - $22,598	-24,299 Reduced 0.49%	4,908,725 $3.34 Million
Q1 2022 May 13, 2022	BUY	$0.84 - $1.71 $2.09 Million - $4.25 Million	2,483,757 Added 101.41%	4,933,024 $4.13 Million
Q4 2021 Feb 11, 2022	BUY	$1.59 - $2.38 $937,514 - $1.4 Million	589,632 Added 31.71%	2,449,267 $3.99 Million
Q3 2021 Nov 12, 2021	BUY	$1.69 - $2.89 $197,491 - $337,722	116,859 Added 6.71%	1,859,635 $4.48 Million
Q2 2021 Aug 13, 2021	BUY	$2.64 - $6.32 $1.37 Million - $3.27 Million	517,532 Added 42.24%	1,742,776 $4.6 Million
Q1 2021 May 14, 2021	BUY	$1.35 - $4.99 $1.65 Million - $6.11 Million	1,225,244 New	1,225,244 $6.11 Million

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $40.5M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Gendell Jeffrey L, based on Form 13F filings with the SEC.

Stay updated on Gendell Jeffrey L with notifications on news.